Journey Medical Corp Quarterly Amortization of Intangible Assets in USD from Q3 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Journey Medical Corp quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2020 to Q1 2024.
  • Journey Medical Corp Amortization of Intangible Assets for the quarter ending March 31, 2024 was $814K, a 23.9% decline year-over-year.
  • Journey Medical Corp annual Amortization of Intangible Assets for 2023 was $3.77M, a 11.9% decline from 2022.
  • Journey Medical Corp annual Amortization of Intangible Assets for 2022 was $4.28M, a 72.9% increase from 2021.
  • Journey Medical Corp annual Amortization of Intangible Assets for 2021 was $2.47M, a 74.2% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $814K -$255K -23.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $4.33M $1.07M +$52K +5.11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $4.28M $1.26M +$770K +157% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $3.51M $1M +$300K +42.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.21M $1M +$300K +42.9% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $2.91M $1.02M +$433K +74.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $2.47M $490K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $700K +$300K +75% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $700K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $584K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $400K Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.